These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 35614588)
21. Psychopathology among anabolic-androgenic steroid using and non-using female athletes in Norway. Scarth M; Jørstad ML; Reierstad A; Klonteig S; Torgersen S; Hullstein IR; Bjørnebekk A J Psychiatr Res; 2022 Nov; 155():295-301. PubMed ID: 36170757 [TBL] [Abstract][Full Text] [Related]
22. Association of Body Dysmorphic-Induced Anabolic-Androgenic Steroid Use With Mental Health Outcomes: A Systematic Review. Gawash A; Zia H; Al-Shehab U; Lo DF Prim Care Companion CNS Disord; 2023 Oct; 25(5):. PubMed ID: 37923553 [No Abstract] [Full Text] [Related]
24. Early Left Ventricular Diastolic Dysfunction, Reduced Baroreflex Sensitivity, and Cardiac Autonomic Imbalance in Anabolic-Androgenic Steroid Users. Kouidi EJ; Kaltsatou A; Anifanti MA; Deligiannis AP Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34209901 [TBL] [Abstract][Full Text] [Related]
26. Sudden cardiac arrest following ventricular fibrillation attributed to anabolic steroid use in an adolescent. Lichtenfeld J; Deal BJ; Crawford S Cardiol Young; 2016 Jun; 26(5):996-8. PubMed ID: 26980272 [TBL] [Abstract][Full Text] [Related]
27. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public. Anawalt BD Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276 [TBL] [Abstract][Full Text] [Related]
28. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Gruber AJ; Pope HG Psychother Psychosom; 2000; 69(1):19-26. PubMed ID: 10601831 [TBL] [Abstract][Full Text] [Related]
29. Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users. Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC Praxis (Bern 1994); 2022 Apr; 111(6):e339-e344. PubMed ID: 35473322 [No Abstract] [Full Text] [Related]
30. Theory of mind in users of anabolic androgenic steroids. Vaskinn A; Hauger LE; Bjørnebekk A Psychopharmacology (Berl); 2020 Oct; 237(10):3191-3199. PubMed ID: 32623552 [TBL] [Abstract][Full Text] [Related]
31. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Pope HG; Katz DL Arch Gen Psychiatry; 1994 May; 51(5):375-82. PubMed ID: 8179461 [TBL] [Abstract][Full Text] [Related]
33. The effects of anabolic-androgenic steroids upon resting and peak exercise left ventricular heart wall motion kinetics in male strength and power athletes. Climstein M; O'Shea P; Adams KJ; DeBeliso M J Sci Med Sport; 2003 Dec; 6(4):387-97. PubMed ID: 14723389 [TBL] [Abstract][Full Text] [Related]
34. Assessing the prevalence and knowledge of anabolic steroid use in male athletes in Al Madina Al Munawara, Saudi Arabia. Alrehaili BD; Miski SF; Alzahrani FM Saudi Med J; 2024 Jul; 45(7):731-740. PubMed ID: 38955450 [TBL] [Abstract][Full Text] [Related]
35. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents. Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932 [TBL] [Abstract][Full Text] [Related]
36. The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review. Davani-Davari D; Karimzadeh I; Khalili H BMC Nephrol; 2019 May; 20(1):198. PubMed ID: 31151420 [TBL] [Abstract][Full Text] [Related]
37. Association between fragmented QRS complexes and left-ventricular dysfunction in anabolic androgenic steroid users. Kaya Ü; Eren H; Öcal L; İnanır M; Balaban İ Acta Cardiol; 2020 Jun; 75(3):244-253. PubMed ID: 31663816 [No Abstract] [Full Text] [Related]
39. Anabolic-androgenic steroid abuse and psychopathology. Porcerelli JH; Sandler BA Psychiatr Clin North Am; 1998 Dec; 21(4):829-33. PubMed ID: 9890124 [TBL] [Abstract][Full Text] [Related]
40. Self-harm behaviour, psychopathological distress and suicidal ideation in normal and deliberate self-harm outpatient's adults. Aqeel M; Nisar HH; Rehna T; Ahmed A J Pak Med Assoc; 2021 Sep; 71(9):2143-2147. PubMed ID: 34580503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]